Lauren M Hurwitz
Overview
Explore the profile of Lauren M Hurwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tadesse D, Rothman N, Xie S, Hurwitz L, Friesen M, Baris D, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39995157
The New England Bladder Cancer Study (NEBCS) has recently reported an increased bladder cancer risk with occupational exposure to mononuclear aromatic organic solvents, including exposure to benzene, toluene, and xylene...
2.
Hurwitz L, Bailey-Whyte M, Daneshvar M, Vocke C, Custer J, Ryan B, et al.
Cancer Causes Control
. 2024 Oct;
36(2):101-106.
PMID: 39390262
Purpose: Surgery, an established short-term immunosuppressive event, may spur dissemination of circulating tumor cells and promote the growth of micrometastases. Whether surgical treatment for prostate cancer (i.e., radical prostatectomy) leads...
3.
Spaur M, Medgyesi D, Bangia K, Madrigal J, Hurwitz L, Beane Freeman L, et al.
J Expo Sci Environ Epidemiol
. 2024 Jul;
PMID: 39003368
Background: Pollutants including metals/metalloids, nitrate, disinfection byproducts, and volatile organic compounds contaminate federally regulated community water systems (CWS) and unregulated domestic wells across the United States. Exposures and associated health...
4.
Remigio R, Andreotti G, Sandler D, Erickson P, Koutros S, Albert P, et al.
Environ Health Perspect
. 2024 Feb;
132(2):27010.
PMID: 38381478
Background: Atrazine is a common agricultural herbicide in the United States. Few epidemiologic studies have evaluated cancer risks. Previous analyses within the Agricultural Health Study (AHS) have found some evidence...
5.
Hurwitz L, Beane Freeman L, Andreotti G, Hofmann J, Parks C, Sandler D, et al.
Environ Res
. 2023 Sep;
237(Pt 2):117063.
PMID: 37659638
More than 200 genetic variants have been independently associated with prostate cancer risk. Studies among farmers have also observed increased prostate cancer risk associated with exposure to specific organophosphate (fonofos,...
6.
Hurwitz L, Dogbe N, Barry K, Koutros S, Berndt S
J Natl Cancer Inst
. 2023 Jun;
115(12):1506-1514.
PMID: 37382561
Background: Though obesity, measured by body mass index (BMI), is an established risk factor for several cancer sites, there is conflicting evidence on whether obesity increases prostate cancer risk or...
7.
Hurwitz L, Webb P, Jordan S, Doherty J, Harris H, Goodman M, et al.
JAMA Netw Open
. 2023 Feb;
6(2):e230666.
PMID: 36826816
Importance: Frequent aspirin use is associated with reduced ovarian cancer risk, but it is unknown whether genetic factors modify this association. Understanding effect modifiers is important given that any use...
8.
Hurwitz L, Townsend M, Jordan S, Patel A, Teras L, Lacey Jr J, et al.
J Clin Oncol
. 2022 Jul;
40(36):4207-4217.
PMID: 35867953
Purpose: Frequent aspirin use has been associated with reduced ovarian cancer risk, but no study has comprehensively assessed for effect modification. We leveraged harmonized, individual-level data from 17 studies to...
9.
Watts E, Perez-Cornago A, Fensom G, Smith-Byrne K, Noor U, Andrews C, et al.
Int J Epidemiol
. 2022 Jun;
52(1):71-86.
PMID: 35726641
Background: Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and...
10.
Watts E, Perez-Cornago A, Fensom G, Smith-Byrne K, Noor U, Andrews C, et al.
Int J Cancer
. 2022 May;
151(7):1033-1046.
PMID: 35579976
Previous studies had limited power to assess the associations of testosterone with aggressive disease as a primary endpoint. Further, the association of genetically predicted testosterone with aggressive disease is not...